In order to investigate whether MIF and its receptor CD74 are involved in the immune regulation during anti-SARS-CoV-2 immune responses, concentrations of MIF and soluble CD74 (sCD74) were quantified in the plasma of patients with mild or severe courses of COVID-19, and compared with healthy controls. The gene discussed is MIF; the disease is COVID-19.